Cumberland Pharmaceuticals - 53 Year Dividend History | CPIX

Historical dividend payout and yield for Cumberland Pharmaceuticals (CPIX) since 1971. The current TTM dividend payout for Cumberland Pharmaceuticals (CPIX) as of November 20, 2024 is $0.00. The current dividend yield for Cumberland Pharmaceuticals as of November 20, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.040B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio